IP Library Granted Patent US 11,124,617
Granted Patent B2
US 11,124,617 · App. 16/374,887 · Granted Sep 21, 2021

Materials coated with calixarenes

Inventors: Ivan Jabin (Brussels, BE); Alice Mattiuzzi (Montigny-le-Tilleul, BE); Corinne Lagrost (Hede-Bazouges, FR); Philippe Hapiot (Acigné, FR); Olivia Reinaud (Paris, FR)
Assignees: UNIVERSITE LIBRE DE BRUXELLES (ULB); CENTER NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); UNIVERSITE DE RENNES 1; UNIVERSITE DE PARIS
C08J7/04C07C43/21C07C43/225C07C59/72C07C69/736C07C205/37C07C217/94C07C245/20C07D333/50C07B2200/11C07C2603/90Y10T428/265
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,124,617
App. No.
16/374,887
Granted
Sep 21, 2021
Kind
B2
Abstract

This invention relates to the direct grafting of a calixarene mostly onto the surface of a material, as well as to a grafting process, and certain calixarene intermediates useful for carrying the grafting process.

Claims (19)

1. A calixarene-diazonium salt of formula (I):

wherein:

A − represents an anion and

X represents CH 2 ;

R 1 , R 2 , R 3 , and R 4 each independently represent hydrogen or C 1-30 alkyl optionally, substituted with one or more substituents each independently selected from the group consisting of halo, carboxylic acid ester, alkyl or benzyl thioester, alkenyl, alkynyl, C 1-30 alkoxy, aryl, substituted aryl, —N 3 , cyano, carboxylic acid, carboxylic acid amide, —OH, amino, amido, imino, carbamate, acyl chloride, ureido, thioureido, mercapto, substituted disulfide; heterocyclic; amino acid and amino acid derivative, peptide, phosphine or phosphine oxide, crown ether, aza-crown ether, cryptand, porphyrin, calixarene, cyclodextrin, resorcinarene, saccharide, and polyethylene glycol; and wherein two or more of R 1 , R 2 , R 3 , and R 4 may be covalently linked either directly or by a bridge that includes oxygen, phosphine, phosphine oxide, sulfur, SO, SO 2 , amino, imino, amido, ureido, thioureido, ester, thioester, alkene, alkyne or alkyl; and

Y 1 , Y 2 , and Y 3 are each independently selected from the group consisting of OH, hydrogen, NO 2 , halogen, and N 2 + A −

provided that the compound of formula (I) is not a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =OH, Y 1 =Y 2 =Y 3 =N 2 + ; or a calixarene wherein X=CH 2 , R 1 =R 3 =OH, R 2 =R 4 =OMe, Y 2 =N 2 + , Y 1 =Y 3 =H.

2. The calixarene-diazonium salt according to claim 1 , wherein A − is a chloride, bromide, or BF 4 − .

3. A process for preparing a calixarene-diazonium salt of formula (I) as defined in claim 1 , wherein a calix-aniline of formula (II):

is converted into the corresponding calixarene-diazonium salt either by in situ diazotation of the amino groups or by diazotation followed by isolation of the diazonium salts of formula (I);

wherein Y 1 , Y 2 , and Y 3 are each independently selected from the group consisting of OH, hydrogen, NO 2 , halogen, and NH 2 X represents CH 2 ;

and R 1 , R 2 , R 3 , and R 4 are as defined in claim 1 .

4. The process according to claim 3 , wherein the calix-aniline of formula (II) as defined in claim 3 , wherein

R 1 , R 2 , R 3 , and R 4 each independently represent hydrogen or C 1-30 alkyl optionally substituted with one or more substituents each independently selected from the group consisting of halo, carboxylic acid ester, alkyl or benzyl thioester, alkenyl, alkynyl, C 1-30 alkoxy, aryl, substituted aryl, —N 3 , cyano, carboxylic acid, carboxylic acid amide, —OH, amino, amido, imino, carbamate, acyl chloride, ureido, thioureido, mercapto, substituted disulfide, heterocyclic, amino acid and amino acid derivative, peptide, phosphine or phosphine oxide, crown ether, azacrown ether, cryptand, porphyrin, calixarene, cyclodextrin, resorcinarene, saccharide, and polyethylene glycol, and wherein two or more of R 1 , R 2 , R 3 , and R 4 may be covalently linked either directly or by a bridge that includes oxygen, phosphine, phosphine oxide, sulfur, SO, SO 2 , amino, imino, amido, ureido, thioureido, ester, thioester, alkene, alkyne or alkyl;

and wherein Y 1 , Y 2 , and Y 3 are each independently selected from the group consisting of OH, hydrogen, NO 2 , halogen and NH 2 ;

provided that the compound of formula (II) is not a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =Pr, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3=Pr and R 4 =CH 2 COOEt, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =OH, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =decyl, Y 1 =NH 2 , Y 2 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =decyl, Y 2 =NH 2 Y 1 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =decyl, Y 1 =Y 2 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =Pr, Y 1 =NH 2 , Y 2 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =Pr, Y 2 =NH 2 Y 1 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =Pr, Y 1 =Y 2 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 3 =OH, R 2 =R 4 =Me, Y 2 =NH 2 , Y 1 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =Me, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =Me, Y 2 =NH 2 , Y 1 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 3 =OH, R 2 =R 4 =Pr, Y 2 =NH 2 , Y 1 =Y 3 =H, a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =undecyl, Y 1 =Y 2 =Y 3 =NH 2 , a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =pentyl, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =CH 2 COOEt, Y 2 =NH 2 , Y 1 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 3 =CH 2 COOEt, R 2 =R 4 =Me, Y 2 =NH 2 , Y 1 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =hexyl, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =butyl, Y 1 =Y 2 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =butyl, Y 1 =NH 2 , Y 2 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =butyl, Y 2 =NH 2 Y 1 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =butyl, Y 1 =Y 2 =NH 2 Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =butyl, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =octyl, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =(CH 2 ) 2 O(CH 2 ) 2 , Y 1 =Y 2 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =(CH 2 ) 2 O(CH 2 ) 2 , Y 1 =NH 2 , Y 2 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =(CH 2 ) 2 O(CH 2 ) 2 , Y 2 =NH 2 Y 1 =Y 3 =H, or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =(CH 2 ) 2 O(CH 2 ) 2 , Y 1 =Y 2 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =R 4 =(CH 2 ) 2 O(CH 2 ) 2 , Y 1 =Y 2 =Y 3 NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 3 =decyl, R 2 =R 4 =Me, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 3 =Pr, R 2 =R 4 =Me, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =Me, R 4 =Pr, Y 1 =Y 2 =Y 3 =NH 2 , or a calixarene wherein X=CH 2 , R 1 =R 2 =R 3 =Pr, R 4 =Me, Y 1 =Y 2 =Y 3 =NH 2 .

5. The process according to claim 3 , wherein all of Y 1 , Y 2 , and Y 3 of the calix-aniline of formula (I) are amino.

6. The calixarene-diazonium salt according to claim 1 , wherein the substituted aryl is substituted with one or more substituents selected from the group consisting of fluoro, cyano, C 1-30 alkyl, and C 1-30 alkoxy.

7. The process according to claim 4 , wherein the substituted aryl of the calix-aniline is substituted with one or more substituents selected from the group consisting of fluoro, cyano, C 1-30 alkyl, and C 1-30 alkoxy.

Assignments (3)
CHANGE OF NAME Recorded Mar 25, 2022
From: UNIVERSITÉ DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 059504/0225 →
MERGER Recorded Jul 22, 2021
From: UNIVERSITE DE PARIS DESCARTES
To: UNIVERSITE DE PARIS
Reel/Frame 056958/0603 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2019
From: JABIN, IVAN; MATTIUZZI, ALICE; LAGROST, CORINNE; HAPIOT, PHILIPPE; REINAUD, OLIVIA
To: UNIVERSITE LIBRE DE BRUXELLES (ULB); CENTER NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); UNIVERSITE DE RENNES 1; UNIVERSITE PARIS DESCARTES
Reel/Frame 048791/0795 →